Danny Lee Freeman v. Andrew Saul

CourtDistrict Court, C.D. California
DecidedJuly 30, 2020
Docket2:19-cv-09099
StatusUnknown

This text of Danny Lee Freeman v. Andrew Saul (Danny Lee Freeman v. Andrew Saul) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Danny Lee Freeman v. Andrew Saul, (C.D. Cal. 2020).

Opinion

3 O

8 UNITED STATES DISTRICT COURT

9 CENTRAL DISTRICT OF CALIFORNIA

11 DANNY LEE F., Case No. 2:19-cv-09099-KES

12 Plaintiff, MEMORANDUM OPINION AND 13 v. ORDER

14 ANDREW M. SAUL, Commissioner of Social Security, 15 Defendant. 16

18 I.

19 PROCEDURAL BACKGROUND

20 In February 2016, Plaintiff Danny Lee F. (“Plaintiff”) applied for Social 21 Security Disability Insurance Benefits, alleging that he became disabled on March 22 13, 2015.1 Administrative Record (“AR”) 189, 193. On February 1, 2018, the 23 Administrative Law Judge (“ALJ”) conducted a hearing at which Plaintiff, who 24 was represented by a non-attorney representative, testified along with a vocational 25 expert (“VE”). AR 33-81. 26

27 1 His previous application for benefits was denied in October 2013. AR 83, 213. 28 1 On October 23, 2018, the ALJ issued an unfavorable decision. AR 12-32. 2 The ALJ found that Plaintiff suffered from the severe medically determinable 3 impairments (“MDIs”) of “lumbago [(i.e., lower back pain)] and status post carpal 4 tunnel release bilaterally.” AR 18. The ALJ determined that Plaintiff’s anxiety, 5 depression, and polysubstance abuse disorder in remission were not severe MDIs. 6 AR 18-19. Despite his MDIs, the ALJ found that Plaintiff had the residual 7 functional capacity (“RFC”) to perform light work, except that he is “limited to 8 frequent fine and gross manipulation bilaterally and frequent postural limitations.” 9 AR 21. 10 Based on this RFC and the VE’s testimony, the ALJ found that Plaintiff 11 could perform his past relevant work as a construction superintendent (DOT 12 182.167-026) as that job is generally performed. AR 24-25. The ALJ also made 13 alternative findings that Plaintiff could work as a collator operator (DOT 208.685- 14 010), routing clerk (DOT 222.687-022), or sales attendant (DOT 299.677-010), all 15 light occupations. AR 25-26. The ALJ concluded that Plaintiff was not disabled. 16 AR 26. 17 II. 18 ISSUES PRESENTED 19 Issue One: Whether the ALJ erred in evaluating the medical opinion 20 evidence about Plaintiff’s mental impairments from Dr. Shuhaibar. (Dkt. 21, Joint 21 Stipulation [“JS”] at 3, 13-19.) 22 Issue Two: Whether the ALJ erred by failing to give specific, germane 23 reasons for discounting the Third Party Statement of Plaintiff’s daughter, Nicole F. 24 (AR 249-56). (JS at 3, 27.) 25 Issue Three: Whether the ALJ erred by failing to consider Plaintiff’s cardiac 26 or cervical spine impairments at steps two through four. (Id. at 3, 32.) 27 Issue Four: Whether the ALJ erred by failing to give clear and convincing 28 reasons for discounting Plaintiff’s subjective symptom testimony. (Id. at 3, 39.) 1 Il. 2 DISCUSSION 3 The Court will discuss the issues out of order to track the sequential 4 | evaluation process for disability benefits eligibility determinations. 5 A. ISSUE ONE: Dr. Shuhaibar’s Opinion. 6 1. Relevant Evidence. 7 a. Treating Records. 8 Plaintiff initially saw Dr. Jasmin Villatoro at Central City Community 9 | Health Center to treat his physical issues. AR 519. She referred him to 10 | psychiatrist Dr. Lina Shuhaibar for his “acute stress and anxiety.” AR 525. 11 | Plaintiffs initial appointment with Dr. Shuhaibar occurred on January 26, 2016. 12 | 507. Dr. Shuhaibar noted his subjective complaints, including aggression, 13 | anxiety, stress caused by conflict with a neighbor, financial worries, and recent 14 | family deaths. AR 507-08, 526. She conducted a depression screening and 15 | assessed that Plaintiff had “mild depression.”” AR 507. She observed that his 16 | mood seemed “depressed” and “anxious.” AR 508. Plaintiff reported a “poor” 17 | appetite and sleep, but the other aspects of his mental status examination were 18 | average or fair. AR 508-09. She started him on Celexa/citalopram, an 19 | antidepressant, and Ativan/lorazepam for anxiety. AR 507. 20 At his next appointment on February 9, 2016, Plaintiff reported that things 21 | were “going much better’; he had an “improved mood” and sleep, “no aggression,” 22 | and “eats well” since starting Celexa. AR 504. He did not need to take lorazepam 23 | for anxiety after the initial dose two weeks earlier. Id. His mental status 24 | examination noted a “stable, happy” mood and “no” disturbance to sleep or 25 | appetite. AR 505. Dr. Shuhaibar rated the efficacy of his treatment “fair to good.” 26 | Id. 27 On February 23, 2016, Plaintiff confirmed he was still taking Celexa but not 28 | lorazepam. AR 502. He denied aggression and was “‘less irritable and anxious.”

1 Id. Dr. Shuhaibar assessed his mood as “stable, improved overall, but still 2 depressed and anxious at times.” AR 503. Otherwise, his mental status 3 examination was similar to before. Id. 4 On March 8, 2016, Plaintiff reported anxiety, bad dreams, and financial 5 worries, but he still had not taken more lorazepam. AR 500. He denied 6 aggression, and his mental status examination reflected a “stable, neutral” mood 7 with other factors largely unchanged. AR 500-01. 8 On March 29, 2016, Plaintiff reported becoming “extremely agitated” that 9 morning due to a gardener’s noisy leaf blower, but by the time of his appointment, 10 he rated his mood as 7/10 (10 being best). AR 498-99. Dr. Shuhaibar noted that 11 he should “work on coping skills.” AR 498. He was still sleeping and eating 12 “OK,” and his treatment efficacy was still “fair to good.” AR 498-99. 13 On April 26, 2016, Plaintiff felt angry with his neighbor and reported feeling 14 “more depressed and hopeless than before.” AR 496. He complained of anxiety 15 and mood swings, but continued not to take lorazepam. Id. Per his mental status 16 examination, Dr. Shuhaibar assessed a “stable” mood with the other factors (all 17 fair, average, or sufficient) unchanged. AR 496-97. 18 By May 31, 2016, Plaintiff felt “OK” and “less” anxious and depressed, but 19 he still reported some feelings of depression and hopelessness. AR 494. Again, 20 his mental status examination was unremarkable, and the efficacy of his treatment 21 was “fair to good.” AR 495. 22 On June 28, 2016, Plaintiff reported having a rough week because he forgot 23 to take his Celexa with him on a three-day fishing trip. AR 492. He was also 24 feeling increased depression due to pain and a reduced ability to help his elderly 25 mother following carpal tunnel release surgery on June 24. AR 492, 566. His 26 mental status examination was unchanged. AR 492-93. His follow-up 27 appointments were rescheduled from monthly to every three months. AR 492. 28 On September 27, 2016, he continued to report conflict with his neighbor 1 and a depressed mood, but he was sleeping and eating “OK.” AR 490. His mental 2 status examination was unremarkable. AR 490-91. 3 In October 2016, Dr. Villatoro conducted another depression screening and 4 again assessed “mild depression.” AR 570, 574-75. She occasionally conducted 5 mental status examinations, all of which revealed no remarkable findings. AR 532, 6 576, 578. 7 On December 27, 2016, Plaintiff was still “doing OK” although he had 8 argued with an electrician. AR 488. His mental status examination was 9 unchanged. AR 488-89. He was still taking the same does of Celexa and not 10 taking lorazepam. AR 488. Dr. Shuhaibar still rated the efficacy of his treatment 11 as “fair to good.” AR 489.2 12 Plaintiff did not have access to Celexa or his other medication in January 13 2017, because he was incarcerated after an altercation with his neighbor.3 AR 591, 14 649, 713. He returned to see Dr. Shuhaibar on May 23, 2017. AR 586. At that 15 time, he was prescribed the same 20 mg dosage of Celexa/citalopram with the 16 same mental status examination results. AR 586-87. 17 In June 2017, Dr. Shuhaibar increased his Celexa/citalopram dosage from 20 18 mg to 40 mg. AR 588. Plaintiff continued to feel “anxious, nervous, depressed.” 19 Id. Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Turner v. Commissioner of Social Security
613 F.3d 1217 (Ninth Circuit, 2010)
Whitney Bros. Co. v. Sprafkin
60 F.3d 8 (First Circuit, 1995)
Molina v. Astrue
674 F.3d 1104 (Ninth Circuit, 2012)
Debbra Hill v. Michael Astrue
698 F.3d 1153 (Ninth Circuit, 2012)
Schlegel Ex Rel. Schlegel v. Wells Fargo Bank, NA
720 F.3d 1204 (Ninth Circuit, 2013)
Sims v. Apfel
530 U.S. 103 (Supreme Court, 2000)
Melvin Harhaw v. Carolyn Colvin
616 F. App'x 316 (Ninth Circuit, 2015)
Tidwell v. Apfel
161 F.3d 599 (Ninth Circuit, 1998)
Meanel v. Apfel
172 F.3d 1111 (Ninth Circuit, 1999)
Salerno v. Astrue
266 F. App'x 570 (Ninth Circuit, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Danny Lee Freeman v. Andrew Saul, Counsel Stack Legal Research, https://law.counselstack.com/opinion/danny-lee-freeman-v-andrew-saul-cacd-2020.